2-propanol has been researched along with Alagille Syndrome in 3 studies
2-Propanol: An isomer of 1-PROPANOL. It is a colorless liquid having disinfectant properties. It is used in the manufacture of acetone and its derivatives and as a solvent. Topically, it is used as an antiseptic.
propan-2-ol : A secondary alcohol that is propane in which one of the hydrogens attached to the central carbon is substituted by a hydroxy group.
Alagille Syndrome: A multisystem disorder that is characterized by aplasia of intrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC), and malformations in the cardiovascular system, the eyes, the vertebral column, and the facies. Major clinical features include JAUNDICE, and congenital heart disease with peripheral PULMONARY STENOSIS. Alagille syndrome may result from heterogeneous gene mutations, including mutations in JAG1 on CHROMOSOME 20 (Type 1) and NOTCH2 on CHROMOSOME 1 (Type 2).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Alagille syndrome is a arteriohepatic dysplasia which is in most cases correlated with ocular disorders." | 1.30 | [Alagille syndrome (arteriohepatic dysplasia): stable ocular findings after 23 years of illness]. ( Groh, MJ; Mayer, UM; Wenkel, H, 1998) |
| "Alagille syndrome is associated with a characteristic group of ocular findings without apparent serious functional significance and probably unrelated to fat-soluble vitamin deficiency." | 1.30 | Ocular abnormalities in Alagille syndrome. ( Aclimandos, WA; Baker, AJ; Bentley, C; Bird, AC; Davies, A; Hingorani, M; Mieli-Vergani, G; Nischal, KK; Vivian, A, 1999) |
| "The Alagille syndrome (arteriohepatic dysplasia) is a well-recognized multiple malformation syndrome consisting of a paucity of intrahepatic bile bile ducts, peripheral pulmonary artery hypoplasia with variable cardiac abnormalities, cholestatic facies, butterfly-like vertebral arch defects, and variable ocular anomalies, most commonly posterior embryotoxon and pigmentary retinopathy." | 1.29 | Ocular anomalies in the alagille syndrome (arteriohepatic dysplasia). ( Brodsky, MC; Cunniff, C, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brodsky, MC | 1 |
| Cunniff, C | 1 |
| Groh, MJ | 1 |
| Wenkel, H | 1 |
| Mayer, UM | 1 |
| Hingorani, M | 1 |
| Nischal, KK | 1 |
| Davies, A | 1 |
| Bentley, C | 1 |
| Vivian, A | 1 |
| Baker, AJ | 1 |
| Mieli-Vergani, G | 1 |
| Bird, AC | 1 |
| Aclimandos, WA | 1 |
3 other studies available for 2-propanol and Alagille Syndrome
| Article | Year |
|---|---|
Ocular anomalies in the alagille syndrome (arteriohepatic dysplasia).
Topics: Adult; Alagille Syndrome; Child; Cornea; Eye Abnormalities; Female; Humans; Hyperplasia; Infant, New | 1993 |
[Alagille syndrome (arteriohepatic dysplasia): stable ocular findings after 23 years of illness].
Topics: Adult; Alagille Syndrome; Atrophy; Follow-Up Studies; Humans; Intraocular Pressure; Iris; Male; Visu | 1998 |
Ocular abnormalities in Alagille syndrome.
Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Adolescent; Alagille Syndrome; Child; Child, P | 1999 |